Benjamin Besse, MD, PhD, on Clinical Tips for Prescribing Atezolizumab as Neoadjuvant Therapy for Resectable NSCLC

Posted: Sunday, October 4, 2020

Benjamin Besse, MD, PhD, of the Gustave Roussy Cancer Centre, talks about the neoadjuvant setting for atezolizumab in resectable non–small cell lung cancer, tips for clinicians prescribing this medication, and how to manage adverse effects of a drug that has shown some activity in early studies.